D-threo-Ritalinic Acid is a chemical compound used as an active pharmaceutical ingredient in the manufacture of pharmaceutical products. It is structurally related to dexmethylphenidate, a central nervous system stimulant employed in the management of attention deficit hyperactivity disorder (ADHD).
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing D-threo-Ritalinic Acid?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Fulvestrant
pharmaceutical raw material
Alclometasone 21-propionate
pharmaceutical raw material
Milbemycin oxime
pharmaceutical raw material
Glucosamine sulfate potassium chloride
pharmaceutical raw material
Alpha-Phenyl-2-piperidineacetic acid hydrochloride
pharmaceutical intermediate
Ritalinic acid
pharmaceutical intermediate
L-threo-Ritalinic Acid
pharmaceutical intermediate
D-erythro-Ritalinic Acid
research compound
(2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetic acid
INGSNVSERUZOAK-VXGBXAGGSA-N
C1CCN[C@H](C1)[C@@H](C2=CC=CC=C2)C(=O)O
Sourcing D-threo-Ritalinic Acid?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.